FDA Grants Accelerated Approval to Iberdomide Combination for Relapsed or Refractory ...

Reports

3

Domains carrying it

3

First reported

13 August 2026

Latest report

13 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 13 August 2026FDA Grants Accelerated Approval to Iberdomide Combination for Relapsed or Refractory ...hmpgloballearningnetwork.com
2. 13 August 2026FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj ...fda.gov

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...12 reports · 12 domains · 17 August 2026
• European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma2 reports · 2 domains · 24 August 2026
• US FDA approves Replimune's skin cancer drug15 reports · 14 domains · 10 August 2026
• FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder14 reports · 12 domains · 1 September 2026
• FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...11 reports · 11 domains · 1 September 2026
• FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer59 reports · 51 domains · 5 September 2026

◆ Share

◆ Evidence

3 reports · 3 domains

• FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj ...fda.gov · 13 August 2026
• FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myelomapharmacytimes.com · 13 August 2026
• FDA Grants Accelerated Approval to Iberdomide Combination for Relapsed or Refractory ...hmpgloballearningnetwork.com · 13 August 2026